Trial intelligence / Profile preview

Patient preference study of frovatriptan versus zolmitriptan for acute migraine treatment

2006-006574-21Phase 4Completed

Sponsor
Laboratori Guidotti
Start
Jun 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of frovatriptan and zolmitriptan in migraine (2 arms), sponsored by Laboratori Guidotti. Primary endpoint: Patient preference for first or second treatment. Started Jun 2007; status: completed.

02

Drugs

frovatriptanzolmitriptan
03

Conditions

migraine

Beyond the preview

Go deeper on 2006-006574-21.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-006574-21.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call